drugset / Trial / NCT06114121
Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section
Timeline
- Start
- 2024-07-10
- Primary completion
- 2024-09-10
- Completion
- 2024-09-10
Outcome
Outcome not reported
Stopped: “Study will no longer be conducted”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupivacaine | Other / unclassified | 0.75 % | — |
| Background | Bupivacaine | Other / unclassified | 1.4 ml | — |
| Background | Bupivacaine | Other / unclassified | 1.7 ml | — |
| Background | Bupivacaine | Other / unclassified | 10 mg | — |
| Background | Bupivacaine | Other / unclassified | 12 mg | — |
| Background | Morphine | Other / unclassified | 100 ug | Intrathecal |
| Background | Ropivacaine | Other / unclassified | 0.5 % | — |
| Background | Ropivacaine | Other / unclassified | 20 ml | — |
| Background | Ropivacaine | Other / unclassified | 40 ml | — |
Indications
No indication recorded.